Search

Filters
Clear All
  • 21
  • 59
  • 2
  • 717

Phase

  • 1
  • 18
  • 17
  • 56
  • 9
  • 78
  • 5
  • 602
  • 716
  • 312
  • 772
  • 27

Found 799 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

R
Ryan T. Pitman, MS, MD
2 months - 24 months
All genders
Observational
What is the purpose of this study?Infants who require formal assessment of their difficulties safely swallowing liquids often have other medical problems and may require multiple other medical visits. The goal of this study is to determine if an infant's neurological status at the start of their swallow assessment and …
J
James Stevens
50 years - 85 years
All genders
Phase 3
Interventional
This study investigates the long-term effects of an investigational medication in individuals with early Alzheimer's disease who have the APOE4/4 genotype. The APOE4/4 genotype is a specific genetic variation associated with an increased risk of Alzheimer's disease. The purpose of this investigation is to evaluate the safety and effectiveness of …
D
Damien G. Patel, MD
18 years - 100 years
All genders
Phase 2
Interventional
What is the purpose of this study?This double blind, randomized, placebo-controlled study will evaluate the efficacy, safety, and tolerability of Auxora in patients with severe AKI who have associated AHRF. Approximately 150 patients with acute kidney injury (AKI) associated with acute hypoxemic respiratory failure (AHRF) will be randomized at up …
A
Ajay Gupta
18 years - 55 years
All genders
Phase 2
Interventional
What is the purpose of this study?In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is a 2-part study.In Part 1, one set of participants will take either BIIB091 or diroximel fumarate (DRF). In Part 2, …
M
Marlene Bultemeher
18 years - 100 years
All genders
Phase 3
Interventional
This study investigates the effectiveness and safety of an investigational medication compared to a placebo in preventing chronic migraine in adults. A migraine is a severe headache with throbbing pain usually on one side of the head, often accompanied by nausea and sensitivity to light and sound. Chronic migraine is …
A
Andrea Haller
16 years - 17 years
All genders
Phase 3
Interventional
This study investigates the safety and effectiveness of an investigational medication for treating migraine in children aged 6 to 17. Migraine is a condition characterized by severe headaches and other symptoms like nausea and sensitivity to light. The study aims to understand how well the investigational medication works for treating …
G
Gulraj Singh Chawla
18 years - 80 years
All genders
Interventional
What is the purpose of this study?At Indiana University AAHC, both sufentanil and intravenous methadone are the standard of care for pain management in patients undergoing neck dissection with free flap reconstruction and both have had great success. In this study, we propose to compare their effectiveness at different post-operative …
G
Greg Durm, MD
18 years - 100 years
All genders
Phase 1
This study investigates the safety and effects of an investigational antibody-drug conjugate in patients with advanced or metastatic solid tumors. The purpose is to understand how the investigational medication works in the body and its impact on tumors. Advanced or metastatic solid tumors are cancers that have spread beyond their …
R
Rolf Kreutz, MD
18 years - 100 years
All genders
Phase 3
Interventional
What is the purpose of this study?The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development of heart disease, thereby preventing new heart attacks or strokes.THIS STUDY IS ENROLLING BY …
D
Domenick Zero, DDS, MS
18 years - 70 years
All genders
Phase 2
Interventional
What is the purpose of this study?The purpose of this study is to demonstrate the comparability of ianalumab exposure following the sub-cutaneous (s.c.) administration of one injection of 300 mg/2 mL auto-injector (AI) versus two injections of 150 mg/1 mL pre-filled syringe (PFS), and to evaluate the safety and tolerability …
661 - 670 of 799